Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2598-2602, Vol. 39, No. 7
Division of Comparative Medicine,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Received 9 February 2001/Returned for modification 2 April
2001/Accepted 21 April 2001
Helicobacter hepaticus infection in mice is being
used as an animal model for elucidating the pathogenesis of
gastrointestinal and biliary diseases in humans. H.
hepaticus, which forms a spreading film on selective agar, is
not amenable to routine quantitative counts of organisms in tissues
using a CFU method. In this study, a fluorogenic PCR-based assay was
developed to quantitatively detect H. hepaticus in mouse
ceca and feces using the ABI Prism 7700 sequence detection system. A
pair of primers and a probe for this assay were generated from the
H. hepaticus cdtB gene (encoding subunit B of the
H. hepaticus cytolethal distending toxin). Using this
assay, the sensitivity for detection of H. hepaticus
chromosomal DNA prepared from pure culture was 20 fg, which is
equivalent to approximately 14 copies of the H.
hepaticus genome based on an estimated genome size of
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2598-2602.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fluorogenic PCR-Based Quantitative Detection of a
Murine Pathogen, Helicobacter hepaticus
1.3 Mb
determined by pulsed-field gel electrophoresis. H.
hepaticus present in feces and cecal samples from H.
hepaticus-infected mice was readily quantified. The selected
PCR primers and probe did not generate fluorescent signals from eight
other helicobacters (H. canis, H.
cineadi, H. felis, H. mustelae, H. nemestrinae, H. pullorum, H. pylori, and H.
rodentium). A fluorescent signal was detected from 20 ng of H. bilis DNA but with much lower
sensitivity (106-fold) than from H.
hepaticus DNA. Therefore, this assay can be used with high
sensitivity and specificity to quantify H. hepaticus in
experimentally infected mouse models as well as in naturally infected mice.
*
Corresponding author. Mailing address: Massachusetts
Institute of Technology, 16-873, 77 Massachusetts Ave., Cambridge, MA 02139. Phone: (617) 253-5518. Fax: (617) 258-5708. E-mail:
zge{at}mit.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|